Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

AVX754 (a New Nucleoside Reverse Transcriptase Inhibitor [NRTI]) to Treat Drug-resistant HIV

This study has been completed.
Information provided by:
Avexa Identifier:
First received: August 3, 2005
Last updated: June 22, 2011
Last verified: June 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2008
  Primary Completion Date: January 2008 (Final data collection date for primary outcome measure)